Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001037389-26-000063·Bolt Biotherapeutics, Inc.
Schedule 13G ownership disclosure
BOLT BIOTHERAPEUTICS INC
Common Stock, $0.00001 par value · CUSIP: 097702203
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Renaissance Technologies LLC
Shares: 92,925 · Class: 4.82%
- Renaissance Technologies Holdings Corporation
Shares: 92,925 · Class: 4.82%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-26-000063
- Form type
- SCHEDULE 13G/A
- Filer
- Bolt Biotherapeutics, Inc.
- CIK
- CIK 1641281
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership